Prevalence of natural and acquired antibodies to amustaline/glutathione pathogen reduced red blood cells.

Transfusion
Christof GeisenErhard Seifried

Abstract

The INTERCEPT™ Blood System for Red Blood Cells (RBCs) utilizes amustaline (S-303) and glutathione (GSH) to inactivate pathogens and leukocytes in transfused RBCs. Treatment-emergent low titer non-hemolytic antibodies to amustaline/GSH RBC were detected in clinical trials using a prior version of the process. The amustaline/GSH process was re-formulated to decrease S-303 RBC adduct formation. A standard three-cell antibody screening panel was modified to include reagent red cells (RRC) with high (S-303H) or low (S-303L) S-303 adduct density as assessed by flow cytometry, representative of the original and current amustaline/GSH treatment processes, respectively. General hospital and RBC transfusion-dependent patients never exposed, and clinical trial subjects exposed to amustaline/GSH RBC were screened for antibodies to amustaline/GSH RBC using a standardized agglutination assay. Twelve (0.1%) of 10,721 general hospital and 5 (0.5%) of 998 repeatedly-transfused patients not previously exposed to amustaline/GSH RBCs expressed natural, low titer (2-32) IgM and/or IgG (non-IgG1 or IgG3 isotype) antibodies with acridine (a structural element of amustaline) (n = 14) or non-acridine (n = 3) specificity. 11 of 17 sera reacted with S-3...Continue Reading

References

Dec 10, 2009·Biologicals : Journal of the International Association of Biological Standardization·N A MuftiL Lin
Jul 23, 2011·Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur̈ Transfusionsmedizin Und Immunham̈atologie·Reinhard HenschlerNina Mufti
Aug 31, 2012·Expert Opinion on Drug Delivery·Ricardo P GarayPascal Richette
Sep 12, 2013·Cytometry. Part B, Clinical Cytometry·Shabnam TangriUNKNOWN ICSH/ICCS Working Group
Jun 2, 2017·Journal of Clinical Laboratory Analysis·Marina C A V ConradoCarla L Dinardo
Aug 25, 2018·Transfusion Medicine Reviews·Tik Nga TongDonald R Branch
May 31, 2019·British Journal of Haematology·Yesim AydinokLaurence Corash
Jun 22, 2019·Journal of Applied Toxicology : JAT·Danica SabolovaMária Kozurkova
Sep 24, 2019·Antibodies·Steven W de TaeyeGestur Vidarsson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.